Liang En Wee
Overview
Explore the profile of Liang En Wee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
777
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tan Y, Loy E, Tan W, Tay A, Lim J, Chiew C, et al.
Am J Obstet Gynecol
. 2025 Mar;
PMID: 40073919
Background: Significant heterogeneity has been reported in estimates of long-term sequelae following SARS-CoV-2 infection in pregnant women, and most studies were conducted pre-Omicron and pre-dated vaccination rollout. Less severe COVID-19...
2.
Wee L, Lim J, Ho R, Chiew C, Young B, Venkatachalam I, et al.
Lancet Reg Health West Pac
. 2025 Mar;
55:101494.
PMID: 40060306
Background: More data is required to contextualise respiratory-syncytial-virus (RSV) disease burden, versus other vaccine-preventable respiratory-viral-infections (RVIs) in older adults. We aimed to compare severity of RSV in hospitalized adults versus...
3.
Ng Q, Wee L, Lim Y, Ong R, Ong C, Venkatachalam I, et al.
Front Public Health
. 2024 Dec;
12:1491087.
PMID: 39737451
Objective: To characterize the public conversations around long COVID, as expressed through X (formerly Twitter) posts from May 2020 to April 2023. Methods: Using X as the data source, we...
4.
Wee L, Lim J, Tan J, Li J, Chiew C, Yung C, et al.
Clin Microbiol Infect
. 2024 Dec;
PMID: 39732395
Objectives: Most studies on long-term sequelae of SARS-CoV-2 infection in children were conducted pre-Omicron and pre-dated vaccination rollout. We examined long-term risk of new-incident multi-systemic sequelae following SARS-CoV-2 Delta/Omicron infection...
5.
Wee L, Lim J, Goel M, Malek M, Chiew C, Ong B, et al.
Clin Infect Dis
. 2024 Dec;
PMID: 39657038
Background: Vaccination has been shown to attenuate the risk of post-acute sequelae following SARS-CoV-2 infection. However, no prior population-based studies have evaluated if updated bivalent boosters reduce risk of post-acute...
6.
Wee L, Tan J, Chiew C, Abisheganaden J, Chotirmall S, Boon Lye D, et al.
Chest
. 2024 Nov;
166(5):e167-e168.
PMID: 39521554
No abstract available.
7.
Wee L, Lim J, Tay A, Chiew C, Young B, Wong B, et al.
Clin Microbiol Infect
. 2024 Oct;
31(1):139-140.
PMID: 39389464
No abstract available.
8.
Wee L, Malek M, Tan J, Chiew C, Lee V, Heng D, et al.
Vaccine
. 2024 Sep;
42(26):126356.
PMID: 39299002
Importance: Assessing population-wide risk-benefit ratio of COVID-19 vaccination remains relevant in the current era of Omicron endemicity and boosting. Assessments of mortality risk and cardiovascular events post-vaccination/infection were generally made...
9.
Wee L, Lim J, Tay A, Chiew C, Young B, Wong B, et al.
Clin Microbiol Infect
. 2024 Aug;
31(1):93-100.
PMID: 39214187
Objectives: Significant heterogeneity has been reported in cohort studies evaluating the impact of early oral antiviral treatment on preventing postacute sequelae after COVID-19. We evaluated the impact of early nirmatrelvir/ritonavir...
10.
Wee L, Lim J, Tay A, Chiew C, Ong B, Boon Lye D, et al.
JAMA Netw Open
. 2024 Aug;
7(8):e2430983.
PMID: 39212988
Importance: Studies have reported increased risk of autoimmune sequelae after SARS-CoV-2 infection. However, risk may potentially be attenuated by milder Omicron (B.1.1.529) variant infection and availability of booster vaccination. Objective:...